Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MNPR | Common Stock | Options Exercise | +2.53K | +16.1% | 18.3K | Mar 31, 2023 | Direct | F1 | ||
holding | MNPR | Common Stock | 49.4K | Mar 31, 2023 | See Footnote | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MNPR | Restricted Stock Units | Options Exercise | $0 | -2.53K | -25% | $0.00 | 7.6K | Mar 31, 2023 | Common Stock | 2.53K | Direct | F1, F3 |
Id | Content |
---|---|
F1 | Represents shares acquired on vesting and settlement of restricted stock units. |
F2 | 49,400 shares of common stock held by the Christopher M. Starr and Sheri L. Starr Revocable Trust over which Dr. Starr serves as Trustee. |
F3 | On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. |